| |
|
|
|
AcelRx Pharmaceuticals Inc.  
|
|
2.79 -0.05 (-0.02%) |
07-16 16:00 |
|
Open: |
2.82 |
Pre close: |
2.84 |
Target:
|
3.53
|
|
High: |
2.9 |
Low: |
2.72 |
Resistance:
|
3.02
3.53
|
|
Volume: |
1,377,547 |
Market Cap: |
220M |
Support:
|
2.40
2.02
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.81
 |
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
2.50 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
3.04  |
Stochastic Oscillator |
%K(14,3):
|
77.67 |
|
MA(250): |
3.09 |
%D(3): |
78.00 |
|
Average Volume(K) |
3-Month: |
166575
|
52-Week |
High:
|
5.05 |
|
10-Days: |
130726 |
Low: |
1.99 |
|
RSI |
RSI(14):
|
58.04 |
Change(%): |
-7.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.756 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
78.91 |
|
EPS Est. Current Year |
-1.120 |
Return on Assets (ttm) |
-27.7 |
Shares Float (M) |
77.85 |
|
EPS Est. Next Year |
-0.940 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.62 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
-22.7 |
% Held by Institutions |
19.73 |
|
Forward EPS |
-0.909 |
Gross Profit (p.s.) |
-0.190 |
Shares Short (K) |
13700 |
|
Book Value (p.s.) |
-0.100 |
EBITDA (p.s.) |
-0.494 |
P/E |
-3.68 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-27.80 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-34.94 |
P/S |
7312326656.00 |
|
Operating Margin |
-1918.77 |
Levered Free Cash Flow
(M) |
-26.96 |
P/CF |
-6.28 |
|
|
|
|
|
|
